A Study to Evaluate Efficacy, Safety and Tolerability of a Medication in Patients With Amyotrophic Lateral Sclerosis (ALS)


The purpose of this study is to investigate a new therapy for the improvement of skeletal muscle function in conditions associated with muscle weakness or fatigue such as Amyotrophic Lateral Sclerosis (ALS). Participants will receive the study drug or a placebo.


  • Approximately 7 study visits over 18 weeks
  • Participants will take a study drug or a placebo
  • Visits will consist of questionnaires, medical exams, muscle strength tests, blood draws, urine collection, an an electrocardiogram (ECG)


  • Diagnosis of ALS (Amyotrophic Lateral Sclerosis)


18 to 65
65 and over



Monetary compensation


Can be done from home



Amyotrophic lateral sclerosis (ALS), Neurology, Neuromuscular Disorders, Motor neuron disease, Lou Gehrig disease

Principal Investigator

James Wymer, MD


Department of Neurology

Contact Information


(352) 294-8948

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at UFStudies@health.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams